alexa Human DHFR Inhibitors: From In Silico To Novel Leads | 62534
ISSN: 2161-0444

Medicinal Chemistry
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

5th International Conference on Medicinal Chemistry & Computer Aided Drug Designing and Drug Delivery

Amit G Nerkar
Savitribai Phule Pune University, India
Posters & Accepted Abstracts: Med chem
DOI: 10.4172/2161-0444.C1.028
Abstract
Background & Aim: Human dihydrofolate reductase is the pivotal enzyme received much attention with its gold standard inhibitor methotrexate. With this inspiration, the research was aimed to design and synthesize dihydrofolate reductase inhibitors (DHFR) for anti-cancer activity. Methods: In silico screening of some Quinazolines by Vlife MDS 4.2 software, their synthesis in vitro and in vivo pharmacological screening were performed to obtain quinazoline leads for hDHFR inhibition. Structure of the ligands were drawn by Marvinsketch to convert 2D molecules to Mol file followed by optimization of ligands by energy minimization and was carried by molecular mechanics force field (MMFF) on V-Life MDS 4.2 software. Lastly Docking was done and docking scores were compared with standard drug Methotrexate for prioritization of molecules. Further these prioritized molecules were synthesized. The reactions were monitored by TLC and synthesized molecules were characterized IR and NMR spectroscopy. At the end the molecules were evaluated for in vitro anticancer assay on ten different cell lines as per National Cancer Institute, Bethesda guidelines, followed by in vivo assay. Results & Conclusion: Molecules showed comparable inhibition both in in-silico and in-vitro assays to that of Methothrexate taken as standard.
Biography

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7